![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » West-Ward Investigations into Metal Contamination Don’t Measure Up
West-Ward Investigations into Metal Contamination Don’t Measure Up
September 10, 2013
West-Ward Pharmaceuticals has received a Form 483 for lax investigations into metal contaminants and batch deficiencies following an inspection of its Eatontown, N.J., plant. Investigators found that West-Ward failed to identify all potential sources of metal contamination for lots of lisinopril and hydrochlorothiazide 20 mg/25 mg tablets, carisoprodol 350 mg, prednisone, USP 10 mg tablets and lisinopril 40 mg tablets.
Drug GMP Report
Drug GMP Report
Upcoming Events
-
21Oct